Method and reagent for inhibiting cancer development

Details Method and reagent for inhibiting cancer development Method and reagent for inhibiting cancer development

C - Chemistry, Metallurgy

12

N

C12N 15/11 (2006.01) A61K 31/70 (2006.01) C07H 21/02 (2006.01) C12N 5/10 (2006.01) C12N 9/00 (2006.01) C12N 15/55 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2135499

2135499 9323057 PCTABS00028 An enzymatic RNA molecule which specifically cleaves mRNA encoded by an mdr-1 gene, or associated with development or maintenance of chronic myelogenous leukemia, promyelocytic leukemia, Burkitt's lymphoma or acute lymphocytic leukemia, follicular lymphoma, B-cell acute lymphocytic leukemia, breast cancer, colon carcinoma, neuroblastoma, and lung cancer.

Affiliated with

Also associated with

Rating

Method and reagent for inhibiting cancer development does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method and reagent for inhibiting cancer development, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and reagent for inhibiting cancer development will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1782093